Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2169/internalmedicine.54.4512 | DOI Listing |
Pediatr Rheumatol Online J
May 2024
Dermatology department, CHU SOUSS-MASSA, Agadir, Morocco.
J Am Acad Dermatol
September 2024
Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Japan.
Mycoses
April 2024
Department of Dermatology, Peking University First Hospital, Beijing, China.
Front Immunol
March 2024
Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Objective: Clinical and prognostic features of Anti-MDA5-Positive Dermatomyositis (MDA5+ DM) are diverse. This study aimed to examine the peripheral immune cell profiles of patients with MDA5+ DM, identify disease endotypes related to the heterogeneous manifestations and prognosis, and guide individualized therapy regimen.
Methods: This inpatient cohort included 123 patients with MDA5+ DM.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!